Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39405

DNM1 Knockout K562 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Pleural effusion

  • Disease:

    Chronic myeloid leukemia

The DNM1 Knockout K-562 Polyclonal Cells offer a CRISPR/Cas9-edited polyclonal population with targeted disruption of the dynamin-1 gene in human K-562 leukemia suspension cells. This loss-of-function model enables investigation of clathrin-mediated endocytosis, GTPase signaling, and dynamin-1 interactions with adaptor proteins such as amphiphysin and endophilin. Ideal for endocytosis mechanism studies, GTPase inhibitor screening, and disease modeling, these cells support transferrin uptake assays, co-immunoprecipitation, immunofluorescence, and phospho-specific western blotting. The polyclonal format provides a robust platform for biochemical and cell-based analyses without clonal selection.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    K562

    Sex of Donor

    Female

    Derived From Site

    In situ; Pleural effusion

    Gene Name

    DNM1

    Gene Identifier

    NCBI Gene ID 1759

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNM1 Knockout K-562 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population harboring targeted disruptions in the DNM1 gene within the human K-562 suspension cell line. This heterogeneous knockout pool provides a robust loss-of-function model for studying dynamin-1-mediated processes without the need for clonal selection, enabling bulk biochemical and cell-based assays that capture population-level phenotypes.

The K-562 host cell line, derived from a 53-year-old female with BCR-ABL1-positive chronic myeloid leukemia in blast crisis, is a highly undifferentiated suspension line that co-expresses erythroid and myeloid markers. Its well-characterized signaling landscape and capacity for multidifferentiation make it a versatile model for hematopoiesis and leukemogenesis, while its suspension growth supports large-scale culture, transfection, and high-throughput screening applications.

Dynamin-1 is a mechanochemical GTPase integral to clathrin-mediated endocytosis and synaptic vesicle recycling. Its activity is regulated by phosphorylation at Ser-774 and Ser-778 by cyclin-dependent kinase 5 (CDK5) and glycogen synthase kinase-3?? (GSK3??), and by calcium/calcineurin-dependent dephosphorylation following neuronal depolarization. Upon recruitment to clathrin-coated pits, dynamin-1 assembles into helical polymers around the vesicle neck, and GTP hydrolysis drives a conformational change that severs the membrane, releasing the nascent vesicle. This process is orchestrated through direct interactions with a network of SH3-domain-containing proteins, including amphiphysin, endophilin, syndapin, and cortactin, which connect dynamin-1 to the clathrin coat, AP-2 adaptor complex, and the actin cytoskeleton. Beyond its canonical role in endocytosis, dynamin-1 participates in EGFR internalization, mTOR signaling, and calcium signaling, highlighting its broader regulatory functions.

In the K-562 background, ectopic expression of dynamin-1 provides a simplified platform to dissect core endocytic machinery without the complexities of neuronal differentiation. The knockout polyclonal cells enable direct measurement of clathrin-mediated uptake via transferrin internalization assays, visualization of clathrin-coated pits by immunofluorescence, and analysis of dynamin-1 protein interactions through co-immunoprecipitation with adaptor proteins. Additionally, phospho-specific western blotting allows investigation of upstream regulatory pathways, including CDK5- and GSK3??-mediated phosphorylation events.

This polyclonal knockout model supports a wide spectrum of research applications, from mechanistic studies of vesicle scission and clathrin coat disassembly to screening of small-molecule dynamin GTPase inhibitors. The cells can be employed in GTPase activity assays, electron microscopic examination of endocytic intermediates, and functional rescue experiments. Furthermore, they offer a relevant system for exploring the molecular pathology of DNM1-linked neurological disorders, such as early infantile epileptic encephalopathy 31 (EIEE31). For additional technical information or support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)